Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke.

At week three, all parameters (9/9) that were significantly affected by stroke showed a trend towards improvement with PD-L1 treatment ( Fig. 3D ).

also in 53,322 other papers